NanoViricides Inc. [NNVC] stock Initiated by Midtown Partners analyst, price target now $5.30


NanoViricides Inc. [AMEX: NNVC] traded at a high on 08/04/22, posting a 48.37 gain after which it closed the day’ session at $3.65. The company report on August 4, 2022 that NanoViricides Reports That It Has Begun Drug Development to Combat Monkeypox Virus.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, reports that it has begun drug development to combat the monkeypox virus.

Specifically, the Company has initiated a program to screen its library of broad-spectrum antiviral nanoviricides against certain poxviruses in order to develop broad-spectrum poxvirus therapeutics that act by mechanisms other than tecovirimat (TPOXX®).

The results of the trading session contributed to over 27175167 shares changing hands. Over the past one week, the price volatility of NanoViricides Inc. stands at 20.31% while the volatility over the past one month is 12.30%.

The market cap for NNVC stock reached $40.70 million, with 11.54 million shares outstanding and 10.96 million shares in the current float. Compared to the average trading volume of 81.34K shares, NNVC reached a trading volume of 27175167 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about NanoViricides Inc. [NNVC]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NNVC shares is $8.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NNVC stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Midtown Partners have made an estimate for NanoViricides Inc. shares, keeping their opinion on the stock as Strong Buy, with their previous recommendation back on February 11, 2015.

The Average True Range (ATR) for NanoViricides Inc. is set at 0.31 The Price to Book ratio for the last quarter was 1.70, with the Price to Cash per share for the same quarter was set at 1.40.

How has NNVC stock performed recently?

NanoViricides Inc. [NNVC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 100.55. With this latest performance, NNVC shares gained by 93.12% in over the last four-week period, additionally plugging by 49.59% over the last 6 months – not to mention a drop of -5.19% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NNVC stock in for the last two-week period is set at 80.83, with the RSI for the last a single of trading hit 86.71, and the three-weeks RSI is set at 75.82 for NanoViricides Inc. [NNVC]. The present Moving Average for the last 50 days of trading for this stock 2.05, while it was recorded at 2.36 for the last single week of trading, and 2.73 for the last 200 days.

NanoViricides Inc. [NNVC]: Deeper insight into the fundamentals

Return on Total Capital for NNVC is now -33.05, given the latest momentum, and Return on Invested Capital for the company is -34.15. Return on Equity for this stock declined to -34.15, with Return on Assets sitting at -32.57. When it comes to the capital structure of this company, NanoViricides Inc. [NNVC] has a Total Debt to Total Equity ratio set at 0.32. Additionally, NNVC Total Debt to Total Capital is recorded at 0.32, with Total Debt to Total Assets ending up at 0.31.

Reflecting on the efficiency of the workforce at the company, NanoViricides Inc. [NNVC] managed to generate an average of -$518,952 per employee.NanoViricides Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 41.20 and a Current Ratio set at 41.20.

Insider trade positions for NanoViricides Inc. [NNVC]

There are presently around $4 million, or 10.10% of NNVC stock, in the hands of institutional investors. The top three institutional holders of NNVC stocks are: VANGUARD GROUP INC with ownership of 427,878, which is approximately 0% of the company’s market cap and around 5.17% of the total institutional ownership; BLACKROCK INC., holding 189,496 shares of the stock with an approximate value of $0.69 million in NNVC stocks shares; and COMPAGNIE LOMBARD ODIER SCMA, currently with $0.55 million in NNVC stock with ownership of nearly 114.286% of the company’s market capitalization.

Positions in NanoViricides Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 7 institutional holders increased their position in NanoViricides Inc. [AMEX:NNVC] by around 126,020 shares. Additionally, 9 investors decreased positions by around 45,083 shares, while 11 investors held positions by with 994,104 shares. The mentioned changes placed institutional holdings at 1,165,207 shares, according to the latest SEC report filing. NNVC stock had 2 new institutional investments in for a total of 4,399 shares, while 4 institutional investors sold positions of 43,069 shares during the same period.